Compare PCRX & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PCRX | QSI |
|---|---|---|
| Founded | 2006 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 273.7M |
| IPO Year | 2011 | N/A |
| Metric | PCRX | QSI |
|---|---|---|
| Price | $26.26 | $1.30 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $32.86 | $2.88 |
| AVG Volume (30 Days) | 723.2K | ★ 4.5M |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.47 | N/A |
| Revenue | ★ $716,791,000.00 | $3,177,000.00 |
| Revenue This Year | $6.24 | N/A |
| Revenue Next Year | $9.53 | $159.68 |
| P/E Ratio | $55.78 | ★ N/A |
| Revenue Growth | 3.14 | ★ 40.20 |
| 52 Week Low | $18.17 | $0.95 |
| 52 Week High | $27.64 | $5.77 |
| Indicator | PCRX | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 72.55 | 39.26 |
| Support Level | $23.63 | $1.26 |
| Resistance Level | $24.81 | $1.54 |
| Average True Range (ATR) | 0.93 | 0.09 |
| MACD | 0.25 | 0.02 |
| Stochastic Oscillator | 100.00 | 16.46 |
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.